These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


232 related items for PubMed ID: 25199000

  • 1. Practical biosafety in the tuberculosis laboratory: containment at the source is what truly counts.
    van Soolingen D, Wisselink HJ, Lumb R, Anthony R, van der Zanden A, Gilpin C.
    Int J Tuberc Lung Dis; 2014 Aug; 18(8):885-9. PubMed ID: 25199000
    [Abstract] [Full Text] [Related]

  • 2. Establishment of Biosafety Level-3 (BSL-3) laboratory: important criteria to consider while designing, constructing, commissioning & operating the facility in Indian setting.
    Mourya DT, Yadav PD, Majumdar TD, Chauhan DS, Katoch VM.
    Indian J Med Res; 2014 Aug; 140(2):171-83. PubMed ID: 25297350
    [Abstract] [Full Text] [Related]

  • 3. Biosafety standards for working with Crimean-Congo hemorrhagic fever virus.
    Weidmann M, Avsic-Zupanc T, Bino S, Bouloy M, Burt F, Chinikar S, Christova I, Dedushaj I, El-Sanousi A, Elaldi N, Hewson R, Hufert FT, Humolli I, Jansen van Vuren P, Koçak Tufan Z, Korukluoglu G, Lyssen P, Mirazimi A, Neyts J, Niedrig M, Ozkul A, Papa A, Paweska J, Sall AA, Schmaljohn CS, Swanepoel R, Uyar Y, Weber F, Zeller H.
    J Gen Virol; 2016 Nov; 97(11):2799-2808. PubMed ID: 27667586
    [Abstract] [Full Text] [Related]

  • 4. Improved Biosafety and Biosecurity Measures and/or Strategies to Tackle Laboratory-Acquired Infections and Related Risks.
    Peng H, Bilal M, Iqbal HMN.
    Int J Environ Res Public Health; 2018 Nov 29; 15(12):. PubMed ID: 30501091
    [Abstract] [Full Text] [Related]

  • 5. Guidelines for Biosafety Training Programs for Workers Assigned to BSL-3 Research Laboratories.
    Homer LC, Alderman TS, Blair HA, Brocard AS, Broussard EE, Ellis RP, Frerotte J, Low EW, McCarthy TR, McCormick JM, Newton JM, Rogers FC, Schlimgen R, Stabenow JM, Stedman D, Warfield C, Ntiforo CA, Whetstone CT, Zimmerman D, Barkley E.
    Biosecur Bioterror; 2013 Mar 29; 11(1):10-9. PubMed ID: 23477631
    [Abstract] [Full Text] [Related]

  • 6. Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories.
    Wurtz N, Papa A, Hukic M, Di Caro A, Leparc-Goffart I, Leroy E, Landini MP, Sekeyova Z, Dumler JS, Bădescu D, Busquets N, Calistri A, Parolin C, Palù G, Christova I, Maurin M, La Scola B, Raoult D.
    Eur J Clin Microbiol Infect Dis; 2016 Aug 29; 35(8):1247-58. PubMed ID: 27234593
    [Abstract] [Full Text] [Related]

  • 7. Acetic Acid Enables Molecular Enumeration of Mycobacterium tuberculosis from Sputum and Eliminates the Need for a Biosafety Level 3 Laboratory.
    Palekyte A, Morkowska A, Billington O, Morris-Jones S, Millard J, Marakalala MJ, Owolabi O, Sambou B, Zumla A, Sutherland JS, McHugh TD, Honeyborne I.
    Clin Chem; 2024 Apr 03; 70(4):642-652. PubMed ID: 38479728
    [Abstract] [Full Text] [Related]

  • 8. Design and Construction of a Biosafety Level 3 Autopsy Laboratory.
    Nolte KB, Muller TB, Denmark AM, Burstein R, Villalobos YA.
    Arch Pathol Lab Med; 2021 Apr 01; 145(4):407-414. PubMed ID: 33307551
    [Abstract] [Full Text] [Related]

  • 9. Maintaining differential pressure gradients does not increase safety inside modern BSL-4 laboratories.
    Kurth A, Weber U, Reichenbacher D.
    Front Bioeng Biotechnol; 2022 Apr 01; 10():953675. PubMed ID: 36110311
    [Abstract] [Full Text] [Related]

  • 10. Standard practice for cell sorting in a BSL-3 facility.
    Perfetto SP, Ambrozak DR, Nguyen R, Roederer M, Koup RA, Holmes KL.
    Methods Mol Biol; 2011 Apr 01; 699():449-69. PubMed ID: 21116997
    [Abstract] [Full Text] [Related]

  • 11. Quantifying Viable M. tuberculosis Safely Obviating the Need for High Containment Facilities.
    Mtafya B, Musisi E, Qwaray P, Sichone E, Walbaum N, Ntinginya NE, Gillespie SH, Sabiiti W.
    Methods Mol Biol; 2024 Apr 01; 2833():145-152. PubMed ID: 38949708
    [Abstract] [Full Text] [Related]

  • 12. [Biohazards in research laboratories].
    Porru S, Chiappin M, Sfriso N.
    G Ital Med Lav Ergon; 2019 Dec 01; 41(4):359-364. PubMed ID: 32126610
    [Abstract] [Full Text] [Related]

  • 13. Certification & validation of biosafety level-2 & biosafety level-3 laboratories in Indian settings & common issues.
    Mourya DT, Yadav PD, Khare A, Khan AH.
    Indian J Med Res; 2017 Oct 01; 146(4):459-467. PubMed ID: 29434059
    [Abstract] [Full Text] [Related]

  • 14. Biosafety in the clinical mycobacteriology laboratory.
    Richmond JY, Knudsen RC, Good RC.
    Clin Lab Med; 1996 Sep 01; 16(3):527-50. PubMed ID: 8866179
    [Abstract] [Full Text] [Related]

  • 15. Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures.
    Janosko K, Holbrook MR, Adams R, Barr J, Bollinger L, Newton JT, Ntiforo C, Coe L, Wada J, Pusl D, Jahrling PB, Kuhn JH, Lackemeyer MG.
    J Vis Exp; 2016 Oct 03; (116):. PubMed ID: 27768063
    [Abstract] [Full Text] [Related]

  • 16. Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent.
    Kaufer AM, Theis T, Lau KA, Gray JL, Rawlinson WD.
    Pathology; 2020 Dec 03; 52(7):790-795. PubMed ID: 33070960
    [Abstract] [Full Text] [Related]

  • 17. Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.
    Kimman TG, Smit E, Klein MR.
    Clin Microbiol Rev; 2008 Jul 03; 21(3):403-25. PubMed ID: 18625678
    [Abstract] [Full Text] [Related]

  • 18. Biosafety level 3 laboratory for autopsies of patients with severe acute respiratory syndrome: principles, practices, and prospects.
    Li L, Gu J, Shi X, Gong E, Li X, Shao H, Shi X, Jiang H, Gao X, Cheng D, Guo L, Wang H, Shi X, Wang P, Zhang Q, Shen B.
    Clin Infect Dis; 2005 Sep 15; 41(6):815-21. PubMed ID: 16107979
    [Abstract] [Full Text] [Related]

  • 19. Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 2. General Practices.
    Mazur S, Holbrook MR, Burdette T, Joselyn N, Barr J, Pusl D, Bollinger L, Coe L, Jahrling PB, Lackemeyer MG, Wada J, Kuhn JH, Janosko K.
    J Vis Exp; 2016 Oct 03; (116):. PubMed ID: 27768081
    [Abstract] [Full Text] [Related]

  • 20. Biosafety Level 4 Laboratory User Training Program, China.
    Xia H, Huang Y, Ma H, Liu B, Xie W, Song D, Yuan Z.
    Emerg Infect Dis; 2019 May 03; 25(5):. PubMed ID: 31002302
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.